Low-intensity extracorporeal shock wave therapy in vasculogenic erectile dysfunction refractory to PDE5 inhibitors: a prospective study with 12- and 18-month outcomes
Li-ESWT is a safe and effective treatment for vasculogenic ED unresponsive to PDE5-Is, with maximum benefit observed within 12 months. Efficacy tends to decline at 18 months. Larger controlled studies are needed to define long-term outcomes.
Authors
- Benedetto Calabrese
- Giuseppe Di Paola
- Andrea Simone Ceresoli
- Simone Di Salvatore
- Mauro Seveso
- Giuseppe Saitta
- Franco Anacleto Mantovani
- Attilio Luigi Meazza
Institutions
- Istituto di Sessuologia Clinica (IT)
- IRCCS Humanitas Research Hospital (IT)
Publication Details
- Journal
- Archivio Italiano di Urologia e Andrologia
- Published
- 2026-03-02
- DOI
- https://doi.org/10.4081/aiua.2026.14707
- Primary Topic
- Sexual function and dysfunction studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00